drugset / Trial / NCT02884440

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery

NCT02884440 ↗

Phase 2 Completed 43 enrolled Rennes University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Timeline

Start
2016-11-07
Primary completion
2019-05-25
Completion
2019-05-25

Outcome

Missed primary endpoint

paper Morphine consumption at 24 hours (28 mg [18-35] in the ropivacaine group versus 25 mg [19-37] in the placebo group [p=.503]) PMID 37031893 ↗

paper placebo group [p=.503]) were not significantly different between the two groups. PMID 37031893 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 75 mg Other
Background Cisatracurium Small molecule 2 mg/ml —
Background Dexamethasone Small molecule 8 mg —
Background Ketamine Small molecule 0.15 mg/kg —
Background Propofol Small molecule 10 mg/ml —
Background Remifentanil Small molecule 50 ug/ml —

Indications